Mineralocorticoids, salt and high blood pressure

Steroids

Volumn 61, Issue 4, 1996, Pages 184-188

  Gómez Sánchez, Elise P ^a,b   Zhou, Mingyi ^a   Gomez Sanchez, Celso E ^a  

^a University of Missouri   (United States)

^b Harry S Truman Memorial VA ^*  (United States)

Author keywords

adrenal regeneration hypertension; Dahl salt sensitive rat; hypertension; mineralocorticoid; neurosteroid

Indexed keywords

CARBENOXOLONE; GLYCYRRHETINIC ACID; MINERALOCORTICOID; MINERALOCORTICOID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; HYPOTHALAMUS; NONHUMAN; PATHOPHYSIOLOGY; PRESSORECEPTOR; RAT; SALT INTAKE; STEROIDOGENESIS; VASCULAR SMOOTH MUSCLE;

ANIMALIA; CANIS FAMILIARIS;

EID: 0029864570     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0039-128X(96)00010-4     Document Type: Conference Paper

References (51)

1. Glorioso N, Tonolo G, Troffa C, Soro A, Manunta P, Madeddu P, Sabino G, Pinna-Parpaglia P, Realdi G (1995). Recognition of markers of response to potassium-canrenoate in essential hypertension. Steroids 60:105-109.
2. Bohr DF (1981). What makes the pressure go up? A hypothesis. Hypertension 3:II-160-II-165.
3. Gomez-Sanchez EPP (1991). What is the role of the central nervous system in mineralocorticoid hypertension? Am J Hypertens 4:374-381.
4. Coirini H, Marusic ET, De Nicola AF, Rainbow TC, McEwen BS (1983). Identification of mineralocorticoid binding sites in rat brain by competition studies and density gradient centrifugation. Neuroendocrinology 37:354-360.
5. De Kloet ER (1991). Brain corticosteroid receptor balance and homeostatic control. Frontiers Neuroendocrinology 12:95-164.
6. Tramposch AF, Lopes OU, Chernicky CL, Ferrario CM (1989). Alternative mechanism for attenuated pressor responses in AV3V-lesioned dogs. Am J Physiol 257:R431-R438.
7. Gomez-Sanchez EP (1986). Intracerebroventricular infusion of aldosterone induces hypertension in rats. Endocrinology 118:819-823.
8. Gomez-Sanchez EP (1988). Dose-response studies of intracerebro-ventricular infusion of aldosterone in sensitized and nonsensitized rats. J Hypertension 6:437-442.
9. Gomez-Sanchez EP, Fort CM, Gomez-Sanchez CE (1990). Intracerebroventricular infusions of RU28318 blocks aldosterone-salt hypertension. Am J Physiol 258:E482-E484.
10. Janiak PC, Lewis SJ, Brody MJ (1990). Role of central mineralocorticoid binding sites in development of hypertension. Am J Physiol 259:R1025-R1034.
11. Gomez-Sanchez EP, Venkataraman MT, Thwaites D (1990). ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension. Am J Physiol 258:E649-E653.
12. Marver D (1986). Models of aldosterone action on sodium transport: emerging concepts. Adv Exp Med Biol 196:153-171.
13. Pamnani MB, Rinaudo MS, Haddy FJ, Cragoe EJ (1988). Effect of 6-iodoamiloride in various models of experimental hypertension. Hypertension 11:445-451.
14. Vigne P, Champigny G, Marsault R, Barbry P, Frelin C. Lazdunski M (1988). A new type of amiloride-sensitive cationic channel in endothelial cells of brain microvessels. J Biol Chem 264:7663-7668.
15. + channel. Am J Physiol 266:L728-L734.
16. Gomez-Sanchez EP, Gomez-Sanchez CE (1994) Effect of central amiloride infusion on mineralocorticoid hypertension. Am J Physiol 267:E754-E758.
17. Dahl LK, Heine M, Tassinari L (1963) Effects of chronic excess salt ingestion: evidence that genetic factors play an important role in susceptibility to experimental hypertension. J Exp Med 115:1173-1190.
18. Rapp JP (1984). Characteristics of Dahl salt-susceptible and salt-resistant rats. In: de Jong, W, (ed) Handbook of Hypertension: Experimental and Genetic Models of Hypertension, Elsevier, Amsterdam-New York-Oxford, pp. 286-295.
19. Rapp JP, Dene H (1985). Development and characteristics of inbred strains of Dahl salt-sensitive and salt-resistant rats. Hypertension 7:340-349.
20. Brody MJ, Haywood JR, Touw KB (1978). Neural mechanisms in hypertension. Annu Rev Physiol 42:441-453.
21. Gomez-Sanchez EP, Fort C, Thwaites D (1992). Central mineralocorticoid receptor antagonism blocks hypertension in Dahl S/JR rats. Am J Physiol 262:E96-E99.
22. Gomez-Sanchez EP, Gomez-Sanchez CE (1995). The effect of the central infusion of benzamil on Dahl S rat hypertension. Am J Physiol 269:H1044-H1047.
23. Wohlfeil S, Neuser D, Morich RJ (1988). Biosynthesis of 18-hydroxydeoxycorticosterone and corticosterone in adrenal tissue of rat strains with salt-dependent hypertension. Clin Exper Hyper Theory & Practice A10(4):617-627.
24. Buckingham JC, Hodges JR (1975). Interrelationships of pituitary and plasma corticosterone during adrenocortical regeneration in the rat. J Endocrinol 67:411-417.
25. Foulkes R, Gardiner SM, Bennett T (1987). Adrenal regeneration hypertension in the rat. J Hypertension 5:637-644.
26. Gomez-Sanchez CE, Gomez-Sanchez EP, Upcavage RJ, Hall EB (1983). Urinary free and serum 19-nor-deoxycorticosterone in adrenal regeneration hypertension. Hypertension 5:I-32-I-34.
27. Bergon L, Gallant S, Brownie AC (1975). Serum 11-deoxycorticosterone levels in adrenal regeneration hypertension under conditions of quiescence and stress. Steroids 25:323.
28. Zhou M, Gomez-Sanchez EP, Foecking MF, Gomez-Sanchez CE (1995). The cytochrome P-450 11b-hydroxylase-B3 (CYP11B3) mRNA is expressed in the rat adrenal. Mol Cell Endocrinol, (in press).
29. Mellon SH, Blair SR, Monis H (1995). P450c11B3 mRNA, transcribed from a third P450c11 gene, is expressed in a tissue-specific, developmentally and hormonally regulated fashion in the rodent adrenal and encodes a protein with both 11-hydroxylase and 18-hydroxylase activities. J Biol Chem 270:1643-1649.
30. Mukai K, Imai M, Shimada H, Ishimura Y (1993). Isolation and characterization of rat CYP11B genes involved in late steps of mineralo- and glucocorticoid synthesis. J Biol Chem 268:9130-9137.
31. Rapp JP, Dahl LK (1971). Adrenal steroidogenesis in rats bred for susceptibility and resistance to the hypertensive effect of salt. Endocrinology 88:52-65.
32. Rapp JP, Dahl LK (1972). Mendelian inheritance of 18 and 11b-steroid hydroxylase activities in the adrenals of rats genetically susceptible or resistant to hypertension. Endocrinology 90:1435-1446.
33. Matsukawa N, Nonaka Y, Higaki J, Nagano M, Mikami H, Ogihara T, Okamoto M (1993) Dahl's salt-resistant normotensive rat has mutations in cytochrome P450 (11b), but the salt-sensitive hypertensive rat does not. J Biol Chem 268:9117-9121.
34. Cicila GT, Rapp JP, Wang J-M, St Lezin E, Ng SC, Kurtz TW (1993). Linkage of 11b-hydroxylase mutations with altered steroid biosynthesis and blood pressure in the Dahl rat. Nat Genet 3:346-353.
35. Griffing GT, Melby JC, Holbrook M, Wilson T, Azar S, Delaney M, Weiss S (1991). Elevated 18-hydroxy-corticosterone in inbred salt-sensitive rats. Clin Exp Hypertens A13(3):371-382.
36. Imai M, Shimada H, Okada Y, Matsuhima-Hibiya Y, Ogishima T, Ishimura Y (1990). Molecular cloning of cDNA encoding aldosterone synthase cytochrome P-450 in rat adrenal cortex. FEBS Lett 263:299-302.
37. Zhou M, Gomez-Sanchez CE (1993). Cloning and expression of a rat cytochrome P-450 11b-hydroxylase/aldosterone synthase (CYP11B2) cDNA variant (correction BBRC 196:1018, 1993). Biochem Biophys Res Commun 194:112-117.
38. Cover CM, Wang J, St Lezin E, Kurtz TW, Mellon SH (1995). Molecular variants in the P450c11AS gene as determinants of aldosterone synthase activity in the Dahl rat model of hypertension. J Biol Chem 270:16555-16560.
39. Fardella CE, Rodriguez H, Hum DW, Mellon SH, Miller WL (1995). Artificial mutations in P450c11AS (aldosterone synthase) can increase enzymatic activity: a model for low-renin hypertension. J Clin Endocrinol Metab 80:1040-1043.
40. Paul SM, Purdy RH (1992). Neuroactive steroids. FASEB J 6:2311-2322.
41. Mellon SH, Deschepper CF (1993). Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain. Brain Res 629:283-292.
42. Le Gascogne C, Robel P, Gouézou M, Sananes N, Baulieu E, Waterman M (1987). Neurosteroids: cytochrome P-450scc in rat brain. Science 237:1212-1215.
43. Hu ZY, Bourreau E, Jung-Testas I, Robel P, Baulieu E (1987). Neurosteroids: oligodendrocyte mitochondria convert cholesterol to pregnenolone. Proc Natl Acad Sci USA 84:8215-8219.
44. Compagnone NA, Bulfone A, Rubenstein JLR, Mellon SH (1995). Expression of the steroidogenic enzyme P450scc in the central and peripheral nervous system during rodent embryogenesis. Endocrinology 136:2689-2696.
45. Koenig HL, Schumacher M, Ferzaz B, Do Thi AN, Ressouches A, Guennoun R, Jung-Testas I, Robel P, Akwa Y, Baulieu EE (1995). Progesterone synthesis and myelin formation by Schwann cells. Science 268:1500-1503.
46. Selye H (1941). The anesthetic effect of steroid hormones. Proc Soc Exp Biol Med 46:116-121.
47. 21-linked monooxygenase system in adult rat brain. J Steroid Biochem Mol Biol 44:163-169.
48. 11b in rat brain. J Neurosci Res 28: 518-524.
49. Hatakeyama H, Miyamori I, Fujita T, Takeda Y, Takeda R, Yamamoto H (1994). Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem 269:24316-24320.
50. Brilla CG, Guarda E, Zhou G, Myers PR, Weber KT (1992). Angiotensin II-mediated aldosterone synthesis in aortic endothelial cells. Circulation 86 (Suppl. 4):I-90.
51. Takeda R, Hatakeyama H, Takeda Y, Iki K, Miyamori I, Sheng WP, Yamamoto H, and Blair IA (1995). Aldosterone biosynthesis and action in vascular cells. Steroids 60:120-124.